Global Biosimilars Market Size Report Segmented by Product (mAbs, Insulin, G-CSF, Erythropoietin, hGH, Interferons, G-CSF), Application (Oncology, Autoimmune, Diabetes, Blood Disorders, Infectious Diseases, Growth Hormone Deficiency), Manufacturing Type (In-house, Contract) Forecast to 2031

This report by Medi-Tech Insights provides the size of the global biosimilars market at the regional and country-level from 2024 to 2031. The report further segments the market by product, application, and manufacturing type.

Market Size & Forecast (2024-2031), By Product, USD Billion

• Monoclonal Antibodies (mAbs)
• Insulin
• Granulocyte-Colony Stimulating Factor (G-CSF)
• Erythropoietin
• Human Growth Hormone (hGH)
• Interferons
• Other Products

Market Size & Forecast (2024-2031), By Application, USD Billion

• Oncology
• Autoimmune Diseases
• Diabetes
• Blood Disorders
• Growth Hormone Deficiency
• Infectious Diseases
• Other Applications

Market Size & Forecast (2024-2031), By Manufacturing Type, USD Billion

• In-house Manufacturing
• Contract Manufacturing

Market Size & Forecast (2024-2031), By Region, USD Billion

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa